MedTrace Logo

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

NCT07275827 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-12-24

No results posted yet for this study

Summary

this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection

Conditions

  • HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG

zinc sulfate

Effect of using Zinc in Helicobacter pylori Treatment

DRUG

Vonoprazan + amoxicillin + clarithromycin

Effect of using Vonoprazan + amoxicillin + clarithromycin in Helicobacter pylori Treatment

DRUG

proton pump inhibitor + amoxicillin

Effect of using proton pump inhibitor + amoxicillin in Helicobacter pylori Treatment

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2026-04-30
Completion
2026-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07275827 on ClinicalTrials.gov